Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidiferphane and Taxanes in Breast Cancer Patients
NCT05074290Phase 2Recruiting
- Sponsor
- University of Florida
- Start
- Mar 2023
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Epidiferphane in chemotherapy-induced peripheral neuropathy (CIPN), Chemotherapy-induced anemia (CIA), sponsored by University of Florida. Started Mar 2023; status: recruiting.
02
Drugs
Epidiferphane
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)Chemotherapy-induced anemia (CIA)
Beyond the preview
Go deeper on NCT05074290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05074290.